OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology (2022) Vol. 26, Iss. 6, pp. 540-551
Closed Access | Times Cited: 9
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology (2022) Vol. 26, Iss. 6, pp. 540-551
Closed Access | Times Cited: 9
Showing 9 citing articles:
KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 4
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 4
Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease
L Cantarelli, Marta Gutiérrez‐Valencia, Leire Leache, et al.
Medicina Clínica (2024) Vol. 163, Iss. 1, pp. 1-7
Closed Access | Times Cited: 2
L Cantarelli, Marta Gutiérrez‐Valencia, Leire Leache, et al.
Medicina Clínica (2024) Vol. 163, Iss. 1, pp. 1-7
Closed Access | Times Cited: 2
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease
Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 10, pp. 809-818
Closed Access | Times Cited: 4
Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, et al.
Clinical and Experimental Nephrology (2023) Vol. 27, Iss. 10, pp. 809-818
Closed Access | Times Cited: 4
Initial eGFR Changes Predict Response to Tolvaptan in ADPKD
Toshio Mochizuki, Miyuki Matsukawa, Toshiki Tanaka, et al.
Kidney360 (2024) Vol. 5, Iss. 4, pp. 522-528
Open Access | Times Cited: 1
Toshio Mochizuki, Miyuki Matsukawa, Toshiki Tanaka, et al.
Kidney360 (2024) Vol. 5, Iss. 4, pp. 522-528
Open Access | Times Cited: 1
Effectiveness of tolvaptan on renal replacement therapy in patients with autosomal dominant polycystic kidney disease: a retrospective cohort study from the TriNetX global collaborative network
Ming‐Ju Wu, Cheng‐Hsu Chen, Shang-Feng Tsai
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 1
Ming‐Ju Wu, Cheng‐Hsu Chen, Shang-Feng Tsai
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 1
Regional variation in tolvaptan prescribing across England: national data and retrospective evaluation from an expert centre
Jiehan Chong, Tess Harris, Albert Ong
Clinical Kidney Journal (2022) Vol. 16, Iss. 1, pp. 61-68
Open Access | Times Cited: 6
Jiehan Chong, Tess Harris, Albert Ong
Clinical Kidney Journal (2022) Vol. 16, Iss. 1, pp. 61-68
Open Access | Times Cited: 6
Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease
L Cantarelli, M. Valencia, Leire Leache, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 1, pp. 1-7
Closed Access
L Cantarelli, M. Valencia, Leire Leache, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 1, pp. 1-7
Closed Access
Tolvaptan in autosomal dominant polycystic kidney disease — a real-life experience
Julia Maria Borowiecka, Leszek Pączek, Mariusz Niemczyk
Medical Research Journal (2024) Vol. 9, Iss. 2, pp. 130-135
Open Access
Julia Maria Borowiecka, Leszek Pączek, Mariusz Niemczyk
Medical Research Journal (2024) Vol. 9, Iss. 2, pp. 130-135
Open Access
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 6, pp. 1008-1015
Closed Access
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 6, pp. 1008-1015
Closed Access
